Cohance Lifesciences appoints Yann D'Herve as CEO of CDMO Business
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
Sigachi Industries has reported total income of Rs. 132.18 crores during the period ended June 30, 2025
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
Deepak has around 25 years of work experience with reputed companies viz. UPL Group, Teva Group, AkzoNobel India, Ranbaxy Laboratories, and Dr. Reddy’s Laboratories
Subscribe To Our Newsletter & Stay Updated